Skip to content
★ Sign in to follow
株式会社PALTAC logo

株式会社PALTAC Stock: price and insider trades · Japan

JP·Mcap JP¥402BHealth Care

株式会社PALTAC: what insiders have been doing

株式会社PALTAC is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). Between 26 October 2025 and 26 October 2026, 3 insiders published 17 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Across the 3,205 companies tracked on its exchange, the median is 3 filings; at 17 filings, this issuer sits above that mark.

There has been no open-market purchase by an insider of 株式会社PALTAC for at least a year.

Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.

Insider Decl.
23
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,704 of 26,911 companies
54.9
score / 100
Value
62
Quality
48
FCF yld5.6%
Earn yld5.5%
EV/EBITDA10.6x
ROE7.3%
Gross mgn7.5%
Net mgn1.8%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥6,630
Analyst consensus
4 analysts
0.00/5
JP¥2,820Target JP¥2,950(-56%)JP¥3,080
Income statement
RevenueJP¥1.2T
Gross profitJP¥92.3B7% margin
EBITDAJP¥38.1B3% margin
Net incomeJP¥22B1.8% margin
Valuation
PER (trailing)18.5x
P/Book1.3x
Beta0.59
Balance sheet & cash
Market capJP¥402B
Total debtJP¥475M
Free Cash FlowJP¥22.6B
Profitability & ownership
ROE7.3%
ROA1.7%
% insiders97.8%
% institutions11.6%
Last declaration on 17 July 2026
Declarations23 total
  • ●
    Related company / holdingExecutives
    24EDINET
    54.0% of flowShareXTKSEDINET:S100YR77
  • ●
    Related company / holdingExecutives
    23EDINET
    46.0% of flowShareXTKSEDINET:S100YPWY
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YDY8
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YDY3
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YDXV
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YDXQ
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YCPB
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YCUX
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YCEM
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YCFJ
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YCFD
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100YCUU
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100Y9ET
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100Y991
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100Y5AM
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100Y49G
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100XB28
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100WBB0
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100SQJO
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100SI4O
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100SBDI
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100QMEE
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100QHP5

23 of 23 declarations

About 株式会社PALTAC

PALTAC Corporation is a Japanese company specializing in the distribution of health and pharmaceutical products. It primarily operates in the health market in Japan.